Evidence map›Paper›PMID 39907392›Full record

Trial reportMovement disorders : official journal of the Movement Disorder Society2025

Long-Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10-Year Follow-Up.

Patricia Krause, Philipp Mahlknecht, Inger Marie Skogseid, Frank Steigerwald, Günther Deuschl, Richard Erasmi, Alfons Schnitzler, Tobias Warnecke, Jörg Müller, Werner Poewe and 9 more

Registry-linked trialAbstract readClinical Trial, Phase IVMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Movement disorders : official journal of the Movement Disorder Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07244549 (Chronic Neurophyhsiological and Kinematic Biomarker Monitoring in Patients With Dystonia and Pallidal Deep Brain Stimulation), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07244549 recruitingnot on this map

Chronic Neurophyhsiological and Kinematic Biomarker Monitoring in Patients With Dystonia and Pallidal Deep Brain Stimulation

TypeobservationalSponsorCharite University, Berlin, GermanyRan2024 to 2028Enrolled25ConditionsDystonia
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Patricia KrauseMovement Disorder and Neuromodulation Unit, Charité, University Medicine Berlin, Berlin, Germany.ORCID 0000-0001-9063-0556
Philipp MahlknechtDepartment of Neurology, Medical University Innsbruck, Innsbruck, Austria.ORCID 0000-0003-0671-0516
Inger Marie SkogseidDepartment of Neurology, Oslo University Hospital, Oslo, Norway.
Frank SteigerwaldDepartment of Neurology, University of Würzburg, Würzburg, Germany.ORCID 0000-0002-8305-1684
Günther DeuschlDepartment of Neurology, Christian-Albrechts-University, Kiel, Germany.ORCID 0000-0002-4176-9196
Richard ErasmiDepartment of Neurology, Christian-Albrechts-University, Kiel, Germany.
Alfons SchnitzlerInstitute of Clinical Neuroscience and Medical Psychology, and Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
Tobias WarneckeDepartment of Neurology, University of Münster, Münster, Germany.
Jörg MüllerDepartment of Neurology, Vivantes Klinikum Spandau, Berlin, Germany.
Werner PoeweDepartment of Neurology, Medical University Innsbruck, Innsbruck, Austria.
Gerd-Helge SchneiderDepartment of Neurosurgery, Charité, University Medicine Berlin, Berlin, Germany.
Jan VesperDepartment of Stereotactic and Functional Neurosurgery, University of Düsseldorf, Düsseldorf, Germany.
Nils WarnekeDepartment of Neurosurgery, University of Münster, Münster, Germany.
Wilhelm EisnerDepartment of Neurosurgery, Medical University Innsbruck, Innsbruck, Austria.
Thomas ProkopDivision of Stereotactic and Functional Neurosurgery, University of Freiburg, Freiburg, Germany.
Jan-Uwe MüllerDepartment of Neurology, Universitätsmedizin Greifswald, Greifswald, Germany.
Jens VolkmannDepartment of Neurology, University of Würzburg, Würzburg, Germany.
Andrea A KühnMovement Disorder and Neuromodulation Unit, Charité, University Medicine Berlin, Berlin, Germany.
Deep‐Brain Stimulation for Dystonia Study Group

Funding

Deutsche Forschungsgemeinschaft SFB 1261 T1Deutsche Forschungsgemeinschaft TRR 295
6 · The paper itself

Abstract

backgroundPallidal neurostimulation is an effective treatment for severe isolated dystonia, but long-term data from clinical trials are lacking.

objectivesTo evaluate long-term efficacy and safety of pallidal neurostimulation in patients with isolated generalized or segmental dystonia.

methodsExtension study of the prospective multicenter trial (n = 40; July 2002 to May 2004), all patients received effective stimulation and underwent regular follow-up. The 10-year follow-up (n = 31) included Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) motor and disability score, Beck Depression Inventory, Beck Anxiety Inventory, and Mattis Dementia Rating Scale. Primary and secondary endpoints compared motor symptoms, disability scores, mood, and cognition changes.

resultsThirty-one patients (12 female), aged 23-72 years, completed the 10-year study extension. Per protocol analysis showed sustained significant improvement in BFMDRS motor scores at 10 years compared with baseline, without significant change from the 6-month or 5-year follow-up. On average, motor scores decreased by 25.3 ± 5.2 points at 10 years (P < 0.0001; 56% improvement). Individual outcomes varied, with 27 responders (≥25% improvement; mean improvement 65.2 ± 21.4%) and 13 non-responders compared with baseline. Sustained improvements were seen in disability, mood, and anxiety scores. Cognition remained stable.

conclusionsThis study presents the longest prospective, multicenter follow-up of pallidal neurostimulation in generalized and segmental dystonia. Two-thirds of patients showed strong and stable long-term improvements of dystonia, confirming sustained efficacy and safety over 10 years in treatment-refractory dystonic patients. However, one-third experienced primary (3/40) or secondary (10/40) treatment failure. Diagnostic advances, including genetic testing, and technological progress in pallidal neurostimulation may help to reduce the non-responder rates in the future. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Indexed as

Deep Brain StimulationDystoniaGlobus PallidusAdultAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedProspective StudiesTreatment OutcomeYoung AdultDBS responsedeep brain stimulationdystonialong‐term follow‐upneurostimulation

Identifiers

PMID39907392
PMCPMC12160999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.